We are live on ! Find out more
PP

Pacifica Partners Portfolio holdings

AUM $332M
1-Year Est. Return 59.28%
This Fund
S&P 500
This Quarter Est. Return
+4.11%
1 Year Est. Return
+59.28%
3 Year Est. Return
+122.71%
5 Year Est. Return
+144.58%
10 Year Est. Return
AUM
$154M
AUM Growth
+$709K
Cap. Flow
+$2.55M
Cap. Flow %
1.66%
Top 10 Hldgs %
34.2%
Holding
509
New
19
Increased
77
Reduced
59
Closed
14

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.64M
2
C icon
Citigroup
C
+$1.48M
3
STZ icon
Constellation Brands
STZ
+$402K
4
VLO icon
Valero Energy
VLO
+$385K
5
BMY icon
Bristol-Myers Squibb
BMY
+$251K

Sector Composition

Rank Sector Weight
1 Financials 17.71%
2 Technology 17.1%
3 Miscellaneous 15.24%
4 Energy 14.76%
5 Communication Services 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
376
Eli Lilly
LLY
$1.01T
$5K ﹤0.01%
21
REMX icon
377
VanEck Rare Earth/Strategic Metals ETF
REMX
$2B
$5K ﹤0.01%
+50
New +$5.38K
SCHR
378
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$5K ﹤0.01%
182
STZ icon
379
Constellation Brands
STZ
$21.1B
$5K ﹤0.01%
24
-1,740
-99% -$402K
XLB icon
380
State Street Materials Select Sector SPDR ETF
XLB
$8.39B
$5K ﹤0.01%
120
SILV
381
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$5K ﹤0.01%
500
AU icon
382
AngloGold Ashanti
AU
$50.9B
$4K ﹤0.01%
150
BBH icon
383
VanEck Biotech ETF
BBH
$463M
$4K ﹤0.01%
25
CL icon
384
Colgate-Palmolive
CL
$69.4B
$4K ﹤0.01%
51
FOX icon
385
Fox Class B
FOX
$25.4B
$4K ﹤0.01%
+90
New +$3.35K
LCTX icon
386
Lineage Cell Therapeutics
LCTX
$268M
$4K ﹤0.01%
2,926
LUV icon
387
Southwest Airlines
LUV
$19.2B
$4K ﹤0.01%
100
NFGC
388
New Found Gold
NFGC
$630M
$4K ﹤0.01%
+600
New +$3.77K
OXY.WS icon
389
Occidental Petroleum Corp Warrants
OXY.WS
$39.1B
$4K ﹤0.01%
154
PBW icon
390
Invesco WilderHill Clean Energy ETF
PBW
$368M
$4K ﹤0.01%
75
SAP icon
391
SAP
SAP
$249B
$4K ﹤0.01%
36
SCHE icon
392
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
$4K ﹤0.01%
136
SHW icon
393
Sherwin-Williams
SHW
$78.5B
$4K ﹤0.01%
15
SRVR icon
394
Pacer Data & Infrastructure Real Estate ETF
SRVR
$331M
$4K ﹤0.01%
100
TFII icon
395
TFI International
TFII
$11B
$4K ﹤0.01%
35
ABB
396
DELISTED
ABB Ltd
ABB
$4K ﹤0.01%
115
AFB
397
AllianceBernstein National Municipal Income Fund
AFB
$291M
$3K ﹤0.01%
254
AME icon
398
Ametek
AME
$53.8B
$3K ﹤0.01%
23
APTV icon
399
Aptiv
APTV
$9.08B
$3K ﹤0.01%
25
BIIB icon
400
Biogen
BIIB
$31.9B
$3K ﹤0.01%
15

Similar funds

Pacifica Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Pacifica Partners held 509 positions worth $154M, up 0.46% from $153M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pacifica Partners's Q1 2022 filing shows 19 new, 77 increased, 59 reduced and 14 closed positions. Its largest new stake was Accenture: 375 shares worth $119K. The largest sale was CVS Health, an estimated $3.64M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Miscellaneous.

  • Pacifica Partners's largest Q1 2022 buy was Accenture: 375 shares worth $119K.
  • Pacifica Partners added most to Starbucks in Q1 2022, an estimated $1.76M increase.
  • Pacifica Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $1.48M.
  • Pacifica Partners fully exited CVS Health in Q1 2022, selling an estimated $3.64M.
  • Pacifica Partners's ten largest holdings make up 34% of its $154M portfolio in Q1 2022.
  • Pacifica Partners opened 19 new positions and closed 14 in Q1 2022.
  • Pacifica Partners's portfolio value rose 0.46% quarter-over-quarter to $154M.

Based on Pacifica Partners's 13F filing for Q1 2022, filed 12 Apr 2022.